Concepedia

Chang Liu

CL

Statistics

Publications

19

Citations

459

H-Index

14

Active since

2013

Affiliations

Heilongjiang University of Chinese Medicine(Current)

Harbin Medical University

First Affiliated Hospital of Harbin Medical University

Tianjin Medical University

Guangzhou Medical University

Chang Liu is an author at Heilongjiang University of Chinese Medicine specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2013–2022

19

Publications

19

6-Bromoindirubin-3′-Oxime Suppresses LPS-Induced Inflammation via Inhibition of the TLR4/NF-κB and TLR4/MAPK Signaling Pathways

Chang Liu, Xin Tang, Wenjing Zhang et al. · Inflammation · 2019 · 75 citations

, , +14

MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma

Guolin Chen, Lu Lu, Chang Liu et al. · PLoS ONE · 2015 · 61 citations · Full text

, , +17

Bioinformatics Analysis of the Prognostic and Biological Significance of ZDHHC-Protein Acyltransferases in Kidney Renal Clear Cell Carcinoma

Zhuang Liu, Chang Liu, Mingming Xiao et al. · Frontiers in Oncology · 2020 · 32 citations · Full text

, , +13

A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis

Ting Lin, Jingxian Gu, Kai Qu et al. · Aging · 2018 · 29 citations · Full text

, , +17

Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis

Chang Liu, Xiang Zhou, Yu Pan et al. · BMC Cancer · 2021 · 29 citations · Full text

, , +17

1–5 of 19